Maternal serum Sortilin-1 level as a potential biomarker for intrahepatic cholestasis of pregnancy
- 6 September 2022
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 38 (11) , 935-938
Abstract
Objective: Intrahepatic cholestasis of pregnancy (ICP) is the most common liver disease related to pregnancy in women. Sortilin-1 is a sorting receptor belonging to the vacuolar protein sorting 10 (Vps10p) domain family, and recent studies have shown that Sortilin-1 has a distinct role in the pathogenesis of biliary fibrosis and cirrhosis. We aimed to evaluate maternal serum Sortilin-1 level as a potential biomarker in pregnant women with intrahepatic cholestasis. Materials and methods: A prospective observational cohort study was conducted. We enrolled 80 pregnant women, 49 with the diagnosis of intrahepatic cholestasis of pregnancy and 31 healthy controls. Then, we measured maternal serum Sortilin-1 levels using an enzyme-linked immunosorbent assay method and compared them between groups. Results: The mean Sortilin-1 level in the ICP group was higher than control group (3.3 ± 1.7 ng/mL vs. 2.0 ± 0.6 ng/mL, respectively, p < .001). The receiver operating characteristic curve (ROC) analysis based on maternal serum Sortilin-1 levels to predict the presence of ICP was 85.3% controls [area under the curve (AUC), 0.853; 95% CI, 0.738–0.938, p < .001]. The optimal cutoff value of Sortilin-1 was 2.24 ng/mL (71.4% sensitivity and 74.2% specificity) to detect intrahepatic cholestasis of pregnancy. Conclusion: Elevated maternal serum Sortilin-1 levels are associated with ICP and can be used as a disease biomarker. Sortilin-1 levels can be combined with total bile acids, transaminases, and blood coagulation profile in the follow-up of ICP.Keywords
This publication has 20 references indexed in Scilit:
- Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver InjuryThe American Journal of Pathology, 2017
- Sortilin: A novel regulator in lipid metabolism and atherogenesisClinica Chimica Acta, 2016
- New Insights on Intrahepatic Cholestasis of PregnancyClinics in Liver Disease, 2016
- Advances in cholangiocyte immunobiologyAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Fibrosis in Autoimmune and Cholestatic Liver DiseaseBest Practice & Research Clinical Gastroenterology, 2011
- The Vps10p-domain receptor familyCellular and Molecular Life Sciences, 2009
- Intrahepatic cholestasis of pregnancyWorld Journal of Gastroenterology, 2009
- Intrahepatic cholestasis of pregnancy-current achievements and unsolved problemsWorld Journal of Gastroenterology, 2008
- Shedding of the luminal domain of the neurotensin receptor-3/sortilin in the HT29 cell lineBiochemical and Biophysical Research Communications, 2002
- Molecular Identification of a Novel Candidate Sorting Receptor Purified from Human Brain by Receptor-associated Protein Affinity ChromatographyJournal of Biological Chemistry, 1997